Osyte develops AI-powered technology for automating and streamlining multi-asset portfolio management for family offices and institutional fund managers.

ROME Therapeutics is a biotechnology company that develops breakthrough medicines for serious diseases, with a focus on an inhibitor of LINE-1 reverse transcriptase for autoimmune diseases, using their proprietary data science platform to identify active repeat elements and assess their roles in disease.